Foundation Awards Milestone Payment to Hollis-Eden Pharmaceuticals
| 1 min read

The Cystic Fibrosis Foundation has awarded a milestone payment totaling $645,000 to Hollis-Eden Pharmaceuticals. The company earned the payment by meeting specific development milestones under an existing collaboration agreement with the Foundation to develop novel, anti-inflammatory therapies for people with CF.

Share this article
Topics
About the CF Foundation | Drug Pipeline
Recent news
CF Foundation Establishes Health Equity Awards to Advance Research Toward Optimal Health Outcomes
News | 5 min read
CF Foundation Honors the Legacy of Joe O’Donnell
News | 4 min read
CF Foundation Invests up to $5M in Clarametyx Biosciences to Develop a New Anti-Bacterial Therapy 
News | 2 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe